OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Scutellarin alleviates cerebral ischemia/reperfusion by suppressing oxidative stress and inflammatory responses via MAPK/NF‐κB pathways in rats
Yuming Zhang, Zhen Zhang, Jun Wang, et al.
Environmental Toxicology (2022) Vol. 37, Iss. 12, pp. 2889-2896
Closed Access | Times Cited: 24

Showing 24 citing articles:

Scutellarin attenuates oxidative stress and neuroinflammation in cerebral ischemia/reperfusion injury through PI3K/Akt-mediated Nrf2 signaling pathways
Xueheng Xie, Handong Wang, Wenxiu Ge, et al.
European Journal of Pharmacology (2023) Vol. 957, pp. 175979-175979
Open Access | Times Cited: 27

Remodeling brain pathological microenvironment to lessen cerebral ischemia injury by multifunctional injectable hydrogels
Wen Zhang, Yang Liu, Zhicun Wang, et al.
Journal of Controlled Release (2024) Vol. 369, pp. 591-603
Closed Access | Times Cited: 14

Neuroprotective effects of gemfibrozil in neurological disorders: Focus on inflammation and molecular mechanisms
Mehraveh Sadeghi Ivraghi, Mohammad Yasin Zamanian, Reena Gupta, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 30, Iss. 3
Open Access | Times Cited: 17

Exploring Chinese herbal medicine for ischemic stroke: insights into microglia and signaling pathways
Wenjing Zhang, Haoqun Xu, Chong Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6

Flavonoids serve as a promising therapeutic agent for ischemic stroke
Hongxin Shu, Qiuye Liao, Zhihao Chen, et al.
Brain Research (2025), pp. 149528-149528
Closed Access

Current advances on the therapeutic potential of scutellarin: an updated review
Yi-Fei Xie, Guotong Sun, Yue Tao, et al.
Natural Products and Bioprospecting (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4

Scutellarin alleviates microglia‐mediated neuroinflammation and apoptosis after ischemic stroke through the PI3K/AKT/GSK3β signaling pathway
Zhaoda Duan, Haolun Chen, Wei Miao, et al.
Journal of Cell Communication and Signaling (2024) Vol. 18, Iss. 2
Open Access | Times Cited: 4

Neuroprotective Effects and Metabolomics Study of Protopanaxatriol (PPT) on Cerebral Ischemia/Reperfusion Injury In Vitro and In Vivo
Fulin Wu, Sihan Lai, Dongxing Fu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1789-1789
Open Access | Times Cited: 10

Understanding mechanistic aspect of the therapeutic role of herbal agents on neuroplasticity in cerebral ischemic-reperfusion injury
Annu Bangar, Heena Khan, Amarjot Kaur, et al.
Journal of Ethnopharmacology (2023) Vol. 319, pp. 117153-117153
Closed Access | Times Cited: 10

Loganin attenuates neuroinflammation after ischemic stroke and fracture by regulating α7nAChR‐mediated microglial polarization
Kang Huo, Jing Xu, Kaige Ma, et al.
Environmental Toxicology (2023) Vol. 38, Iss. 4, pp. 926-940
Closed Access | Times Cited: 9

Scutellarin: pharmacological effects and therapeutic mechanisms in chronic diseases
Shanshan Nie, Shan Zhang, Ruipeng Wu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3

Scutellarin Suppressed Proliferation and Induced Apoptosis in Gastric Cancer via Wnt/β-catenin Signaling Pathway
Zheng Liu, Zhenkai Wang, Xiang Liu, et al.
Current Pharmaceutical Design (2023) Vol. 29, Iss. 5, pp. 368-378
Closed Access | Times Cited: 8

PLGA nanoparticles enhanced cardio-protection of scutellarin and paeoniflorin against isoproterenol-induced myocardial ischemia in rats
Chang Yang, Shanshan Yang, Shumei Fang, et al.
International Journal of Pharmaceutics (2023) Vol. 648, pp. 123567-123567
Closed Access | Times Cited: 8

Scutellarin ameliorates ischemia/reperfusion injury‑induced cardiomyocyte apoptosis and cardiac dysfunction via inhibition of the cGAS‑STING pathway
Jiu-Kang Li, Zhiping Song, Xing-Zhi Hou
Experimental and Therapeutic Medicine (2023) Vol. 25, Iss. 4
Open Access | Times Cited: 7

Mechanism of scutellarin inhibition of astrocyte activation to type A1 after ischemic stroke
Yongwei Zou, Jingchun Pei, Cheng Wan, et al.
Journal of Stroke and Cerebrovascular Diseases (2024) Vol. 33, Iss. 3, pp. 107534-107534
Open Access | Times Cited: 2

Pharmacological effects and the related mechanism of scutellarin on inflammation-related diseases: a review
Yang Zhou, Chenlin Gu, Yan Zhu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2

The Recent Applications of PLGA-Based Nanostructures for Ischemic Stroke
Jun Yan, Lei Huang, Juan Feng, et al.
Pharmaceutics (2023) Vol. 15, Iss. 9, pp. 2322-2322
Open Access | Times Cited: 6

The Link between Stroke Risk and Orodental Status—A Comprehensive Review
Shahriar Shahi, Mehdi Farhoudi, Solmaz Maleki Dizaj, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 19, pp. 5854-5854
Open Access | Times Cited: 8

DCPIB Attenuates Ischemia–Reperfusion Injury by Regulating Microglial M1/M2 Polarization and Oxidative Stress
Guihua Cao, Jianbin Guo, Kaikai Yang, et al.
Neuroscience (2024) Vol. 551, pp. 119-131
Closed Access | Times Cited: 1

Design and development of nanoselenium-ruthenium/collagen-loaded multifunctional injectable hydrogel delivery for promising treatment of myocardial infarction
Min Wang, Tianming Dai, Dan Zhu
Journal of Drug Delivery Science and Technology (2024), pp. 106522-106522
Closed Access

Isolation of a novel isoprenylated phenolic compound and neuroprotective evaluation of Dodonaea viscosa extract against cerebral ischaemia–reperfusion injury in rats
Omer M. Almarfadi, Nasir A. Siddiqui, Abdelaaty A. Shahat, et al.
Saudi Pharmaceutical Journal (2023) Vol. 32, Iss. 1, pp. 101898-101898
Open Access | Times Cited: 1

Page 1

Scroll to top